Nobilis Therapeutics published an article “Combining Xenon Inhalation With Trauma Memory Reactivation to Reduce Symptoms of Posttraumatic Stress Disorder: Case Report, Justification of Approach, and Review of the Literature” in Primary Care Companion For CNS Disorders

The article centers around a fascinating case report of a patient who had suffered from PTSD for 8 years and who, after receiving the course of treatment with xenon-augmented memory reconsolidation, was reported to have a complete recovery from symptoms of this...

Nobilis Therapeutics Enters into Collaboration with The Linde Group to Support Its Clinical Research Program to Study a drug/device combination for Treatment of PTSD and Other CNS Disorders.

PORTLAND, Ore., January 10, 2019 (Newswire.com) – ​​Nobilis Therapeutics, a biopharmaceutical company focused on the advancement of innovative Central Nervous System therapies based upon the use of noble gas mixtures, today announced that it has entered into a...